Low prevalence of p53, p16INK4a and Ha‐ras tumour‐specific mutations in low‐graded actinic keratosis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  British Journal of Dermatology

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2133.2007.07857.xPMID 17488404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural basis for understanding oncogenic p53 mutations and designing rescue drugs

  2006cited by this paper
• The age of cancer.

  2006cited by this paper
• Oncogenic Ras in tumour progression and metastasis

  2005cited by this paper
• Non-melanoma skin cancer: what drives tumor development and progression?

  2005cited by this paper
• Role of apoptosis in basal cell and squamous cell carcinoma formation.

  2005cited by this paper
• Tumor suppressor genetics.

  2005cited by this paper
• Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma.

  2005cited by this paper
• Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma

  2004cited by this paper
• DNA damage tumor suppressor genes and genomic instability.

  2004cited by this paper
• p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.

  2004cited by this paper
• The CDKN2A database: Integrating allelic variants with evolution, structure, function, and disease association

  2004cited by this paper
• High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.

  2003cited by this paper
• HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene

  2003cited by this paper
• The actinic (solar) keratosis: a 21st-century perspective.

  2003cited by this paper
• Skin cancers after organ transplantation.

  2003cited by this paper
• Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants

  2003cited by this paper
• Skin cancers after organ transplantation.

  2003cited by this paper
• Solar keratosis is squamous cell carcinoma.

  2003cited by this paper
• TP53 mutations in human skin cancers

  2003cited by this paper
• Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin

  2003cited by this paper
• Targeting RAS signalling pathways in cancer therapy

  2003cited by this paper
• Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.

  2002cited by this paper
• Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor.

  2002cited by this paper
• Ras Family Signaling: Therapeutic Targeting

  2002cited by this paper
• UV‐B‐type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas

  2002cited by this paper
• Regulation of G1 cell-cycle progression by oncogenes and tumor suppressor genes

  2002cited by this paper
• Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.

  2002cited by this paper
• Caretaker tumour suppressor genes that defend genome integrity.

  2002cited by this paper
• The IARC TP53 database: New online mutation analysis and recommendations to users

  2002cited by this paper
• Assessing TP53 status in human tumours to evaluate clinical outcome

  2001cited by this paper
• Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.

  2001cited by this paper
• Small GTP-binding proteins.

  2001cited by this paper
• High Mutation Frequency at Ha-ras Exons 1–4 in Squamous Cell Carcinomas from PUVA-treated Psoriasis Patients¶

  2001cited by this paper
• Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").

  2000cited by this paper
• The nature of solar keratosis: a critical review in historical perspective.

  2000cited by this paper
• Epidemiology of actinic keratoses and squamous cell carcinoma.

  2000cited by this paper
• Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients.

  2000cited by this paper
• The age of cancer

  2000cited by this paper
• p53 and human cancer: the first ten thousand mutations.

  2000cited by this paper
• Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.

  1999cited by this paper
• Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratoses.

  1999cited by this paper
• P16 UV mutations in human skin epithelial tumors

  1999cited by this paper
• Role of the p16 tumor suppressor gene in cancer.

  1998cited by this paper
• Alterations of p53 gene and Ha‐ras gene are independent events in solar keratosis and squamous cell carcinoma

  1998cited by this paper
• Mutations of the INK4a locus in squamous cell carcinomas of human skin.

  1997cited by this paper
• CDKN2A (p16INK4A) somatic and germline mutations

  1996cited by this paper
• Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion.

  1996cited by this paper
• Compilation of somatic mutations of the CDKN2 gene in human cancers: Non‐random distribution of base substitutions

  1996cited by this paper
• Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas.

  1995cited by this paper
• Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in human skin.

  1994cited by this paper
• Can we predict solar ultraviolet radiation as the causal event in human tumours by analysing the mutation spectra of the p53 gene?

  1994cited by this paper
• Sunburn and p53 in the onset of skin cancer

  1994cited by this paper
• Codon 12 Harvey‐ras mutations are rare events in non‐melanoma human skin cancer

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers.

  1993cited by this paper
• Small GTP-binding proteins.

  1992cited by this paper
• Squamous cell carcinoma of the skin (excluding lip and oral mucosa).

  1992cited by this paper
• Molecular alterations in human skin tumors.

  1992cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.

  1991cited by this paper
• Ras gene mutation and amplification in human nonmelanoma skin cancers

  1991cited by this paper
• Low incidence of Ha-ras oncogene mutations in human epidermal tumors.

  1991cited by this paper
• Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin.

  1990cited by this paper
• Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation?

  1989cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• ras genes.

  1987cited by this paper
• Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis

  1986cited by this paper

• Genetic Studies of Actinic Keratosis Development: Where Are We Now?

  2023influential citation
• The genetics of cutaneous squamous cell carcinogenesis

  2018cites this paper
• 5-Fluorouracil Enhances Protoporphyrin IX Accumulation and Lesion Clearance during Photodynamic Therapy of Actinic Keratoses: A Mechanism-Based Clinical Trial

  2018cites this paper
• Genetic alterations in seborrheic keratoses

  2017cites this paper
• Fractionation of a tumor-initiating UV dose introduces DNA damage-retaining cells in hairless mouse skin and renders subsequent TPA-promoted tumors non-regressing

  2016cites this paper
• Efficacy and safety of follow‐up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12‐month study

  2016cites this paper
• Photodynamic therapy of the surface form of basalioma and actinic keratosis with the topical administration of methyl aminolevulinate

  2015cites this paper
• Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer

  2015cites this paper
• The Pennsylvania State University The Graduate School Department of Public Health Sciences BUNDLED PAYMENT MODELS FOR ACTINIC KERATOSIS

  2014cites this paper
• Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses

  2013cites this paper
• Drug safety evaluation of vemurafenib in the treatment of melanoma

  2013cites this paper
• PAPEL DA IMUNO-HISTOQUÍMICA NA DISTINÇÃO ENTRE A HIPERPLASIA PSEUDOEPITELIOMATOSA E O CARCINOMA

  2013cites this paper
• The role of genetic factors in skin cancerogenesis

  2013cites this paper
• Reduced P53 Staining in Actinic Keratosis is Associated with Squamous Cell Carcinoma: A Preliminary Study

  2013cites this paper
• Da queratose actínica ao carcinoma espinocelular.

  2012cites this paper
• Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology

  2012cites this paper
• Actinic keratosis: a clinical and epidemiological revision.

  2012cites this paper
• From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

  2012cites this paper
• RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.

  2012cites this paper
• Eyebrow hairs contained the highest number of cutaneous 1 human papillomaviruses from actinic keratosis patients

  2012cites this paper
• Melanoma and Other Skin Cancers

  2012cites this paper
• Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease

  2010cites this paper
• Curcuminoids activate p38 MAP kinases and promote UVB‐dependent signalling in keratinocytes

  2010cites this paper
• Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/hyaluronic acid correlates with downregulation of c-FLIP.

  2010cites this paper
• UV‐induced squamous cell carcinoma – a role for antiapoptotic signalling pathways

  2009cites this paper
• Deregulation of cell‐death pathways as the cornerstone of skin diseases

  2009cites this paper
• Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?

  2007cites this paper
• Tumors of surface epithelium.

  2005cites this paper